Bone marrow involvement by CD1a-negative langerhans cell histiocytosis with associated hemophagocytosis Muntadhar Al MoosawiKrista Marcon Images in Hematology 06 January 2021 Pages: 471 - 472
A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients Shurui ChenToru KiguchiYoshiki Akatsuka Rapid Communication 28 January 2021 Pages: 473 - 479
Validation of an analytical method for the quantification of human fibrinogen in pharmaceutical products by size-exclusion liquid chromatography (SEC-HPLC) RocĂo Hernández-LongoriaYadira Hernández-RuizAbraham ZarazĂşa Original Article 26 February 2021 Pages: 480 - 492
Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A Yuni YamakiTakashi FukushimaHidetoshi Takada Original Article 01 January 2021 Pages: 493 - 499
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis Soji MorishitaTomonori OchiaiNorio Komatsu Original Article 02 January 2021 Pages: 500 - 507
Clostridium perfringens sepsis in three patients with acute leukemia and review of the literature Fuhong LiuSong XueJingbo Wang Original Article 02 January 2021 Pages: 508 - 517
Effect of donor type on volume of blood transfusions required after allogeneic hematopoietic cell transplantation Saiko KurosawaTakuhiro YamaguchiTakahiro Fukuda Original Article 03 January 2021 Pages: 518 - 529
Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization Masahiro IekoTaeko HottaDongchon Kang Original Article 08 January 2021 Pages: 530 - 536
Glycosylated ferritin as an improved marker for post-transfusion iron overload Ayako IshiharaTsuyuko YamauchiHirotaka Matsui Original Article 05 January 2021 Pages: 537 - 546
The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia Yu-juan XueYu WangLe-ping Zhang Original Article 01 January 2021 Pages: 547 - 555
Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation Oranooj LertkovitUsanarat AnurathapanSamart Pakakasama Original Article 01 January 2021 Pages: 556 - 565
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study Takafumi SoejimaMasaaki ShioharaTakuya Yamashita Original Article 02 January 2021 Pages: 566 - 575
Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima Kingo FujimuraAya SugiyamaJunko Tanaka Original Article 03 January 2021 Pages: 576 - 585
Monitoring of MYD88 L265P mutation by droplet digital polymerase chain reaction for prediction of early relapse in a patient with Bing–Neel syndrome Hisaharu ShikataHisafumi KiharaKeiichiro Hattori Case Report 22 November 2020 Pages: 586 - 591
Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein–Barr virus-positive follicular lymphoma Yuri MiyazawaAkihiko YokohamaHiroshi Handa Case Report 02 January 2021 Pages: 592 - 599
Correlation between increased immune checkpoint molecule expression and refractoriness to blinatumomab evaluated by longitudinal T cell analysis Takahiro KobayashiKumi UbukawaNaoto Takahashi Case Report 02 January 2021 Pages: 600 - 605
A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor Ryujiro HaraHiroshi KawadaKiyoshi Ando Case Report 03 January 2021 Pages: 606 - 610
Correction to: Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study Koji IzutsuMichinori OguraMiyako Hoshino Correction 18 February 2021 Pages: 611 - 611
